10 Cheap NASDAQ Stocks to Buy Right Now
On April 28, Gabelli's John Belton joined CNBC's 'Closing Bell Overtime' to analyze the market environment heading into earnings season.
Gilead Sciences Inc. (GILD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 3,982,185 | $554,997,124 | +3% | 0.09% |
| 2. | Holocene Advisors Brandon Haley | 2,611,826 | $364,010,190 | -38% | 0.88% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,310,515 | $322,016,475 | +192% | 0.32% |
| 4. | Renaissance Technologies Jim Simons | 2,152,528 | $299,997,827 | -23% | 0.47% |
| 5. | 1,481,200 | $206,434,844 | +32% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.92 | 10,000 | $999,150.00 | 88,173 | 2015-02-06 | Filing | |
| $43.05 | 10,000 | $430,493.00 | 69,458 | 2013-02-28 | Filing | |
| $44.00 | 10,000 | $439,955.00 | 26,097 | 2012-02-22 | Filing | |
| $38.60 | 8,704 | $335,974.40 | 12,800 | 2010-05-04 | Filing | |
| $38.59 | 4,096 | $158,064.64 | 4,096 | 2010-05-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $132.27 | 3,000 | $396,810.00 | 173,191 | 2026-05-15 | Filing | |
| $132.75 | 700 | $92,925.98 | 125,779 | 2026-05-15 | Filing | |
| $132.23 | 8,374 | $1,107,314.12 | 126,479 | 2026-05-15 | Filing | |
| $131.19 | 11,177 | $1,466,329.63 | 134,853 | 2026-05-15 | Filing | |
| $130.29 | 7,749 | $1,009,628.83 | 146,030 | 2026-05-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 119,010,973 | $16,586,559,275 | 0.29% | |
| 2. | 80,654,776 | $11,240,856,131 | 0.27% | |
| 3. | 71,906,290 | $10,021,579,771 | 0.53% | |
| 4. | 59,858,585 | $8,342,490,991 | 0.29% | |
| 5. | 41,283,933 | $5,753,020,069 | 0.78% |
News See All
12 Best Dividend Stocks to Invest In According to Hedge Funds
Investors tend to favor dividend stocks in times of market volatility and economic uncertainty, as we have seen in recent months.
14 Best Extremely Profitable Stocks to Buy According to Wall Street Analysts
More than two-thirds into the first-quarter reporting season, S&P 500 companies are set to report their strongest quarterly earnings growth in over four years, Reuters reported on May 6, 2026.
10 Best Long Term Low Risk Stocks to Buy According to Hedge Funds
In its report on low-risk investments, TD Asset Management said low-volatility investing can help reduce downside risk while still delivering solid long-term returns.
Gilead Sciences, Inc. (GILD) Outlook Cut Sharply on $11.5B IPR&D and Financing Costs
TheFly reported on May 7 that GILD revised its fiscal 2026 outlook, now expecting adjusted earnings per share between a loss of $1.05 and a loss of $0.65, compared with prior guidance of $8.45 to $8.85...
10 Best Cancer Stocks to Buy for the Long Term
Pharmaceutical firms have always had a special place in the healthcare market because they provide stability and expansion.
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2026 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to Gilead Sciences, Inc.'s First Quarter 2026 Earnings Conference Call. My name is Rebecca, and I will be today's host.
Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now?
Is GILD a good stock to buy? We came across a bullish thesis on Gilead Sciences, Inc. on Trevor Young’s Substack. In this article, we will summarize the bulls’ thesis on GILD.
Gilead Sciences (GILD) Set to Acquire Arcellx
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best stem cell therapy stocks to buy. Gilead Sciences, Inc.
8 Best Stem Cell Therapy Stocks to Buy
He stated that he is not surprised at the market resilience in the face of risk factors such as the war, oil prices, and inflation, looking at the behavior of the S&P 500 and the equity market more broadly...
Hedge Fund Resource Center